Big pharma, Insight journal - Dealtalk, M&A, Pharma

Big pharma Watson may announce $6 billion deal for Actavis

Posted on 25 April 2012

Tags: , , , ,

Big pharma Watson Pharmaceuticals Inc. (WPI) might announce a deal to buy Actavis for  around $6 billion on Wednesday, the Reuters news agency said Monday on its  website, citing unnamed sources familiar with the matter.

The deal, first reported in March, is likely to be valued at EUR 4.25 billion  ($5.6 billion), less than the expected EUR 5-5.5 billion, the report said,  citing a source.

Read more: Link no longer active



Read: more on dealtalk in pharma, biotech, life science partnering deal news, insights and glossary

Read: Big pharma deal news - latest deal news for top 50 pharma / big pharma companies

Report: Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals)

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply